HSBC Holdings’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $259K | Buy |
+5,281
| New | +$259K | ﹤0.01% | 2076 |
|
|
2025
Q1 | – | Sell |
-17,496
| Closed | -$685K | – | 2602 |
|
|
2024
Q4 | $685K | Buy |
17,496
+2,426
| +16% | +$95K | ﹤0.01% | 1622 |
|
|
2024
Q3 | $709K | Sell |
15,070
-11,795
| -44% | -$555K | ﹤0.01% | 1503 |
|
|
2024
Q2 | $1.45M | Buy |
+26,865
| New | +$1.45M | ﹤0.01% | 1235 |
|
|
2022
Q3 | – | Sell |
-11,548
| Closed | -$715K | – | 2510 |
|
|
2022
Q2 | $715K | Sell |
11,548
-8,324
| -42% | -$515K | ﹤0.01% | 1745 |
|
|
2022
Q1 | $1.26M | Buy |
19,872
+1,333
| +7% | +$84.3K | ﹤0.01% | 1513 |
|
|
2021
Q4 | $1.42M | Buy |
18,539
+5,575
| +43% | +$428K | ﹤0.01% | 1467 |
|
|
2021
Q3 | $1.47M | Buy |
12,964
+1,823
| +16% | +$207K | ﹤0.01% | 1325 |
|
|
2021
Q2 | $1.82M | Sell |
11,141
-2,044
| -16% | -$334K | ﹤0.01% | 1179 |
|
|
2021
Q1 | $1.61M | Buy |
13,185
+2,011
| +18% | +$245K | ﹤0.01% | 1118 |
|
|
2020
Q4 | $1.73M | Buy |
11,174
+6,602
| +144% | +$1.02M | ﹤0.01% | 1073 |
|
|
2020
Q3 | $390K | Buy |
4,572
+1,820
| +66% | +$155K | ﹤0.01% | 1695 |
|
|
2020
Q2 | $202K | Sell |
2,752
-24,141
| -90% | -$1.77M | ﹤0.01% | 1979 |
|
|
2020
Q1 | $1.12M | Buy |
+26,893
| New | +$1.12M | ﹤0.01% | 1072 |
|